Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China

Previous economic studies conducted in developed countries showed intravenous tissue-type plasminogen activator (tPA) is cost-effective for acute ischemic stroke. The present study aimed to determine the cost-effectiveness of tPA treatment in China, the largest developing country. A combination of d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2014-10, Vol.9 (10), p.e110525-e110525
Hauptverfasser:	Pan, Yuesong, Chen, Qidong, Zhao, Xingquan, Liao, Xiaoling, Wang, Chunjuan, Du, Wanliang, Liu, Gaifen, Liu, Liping, Wang, Chunxue, Wang, Yilong, Wang, Yongjun
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Brain Ischemia - drug therapy Brain Ischemia - economics Cardiac arrhythmia China Computer simulation Cost analysis Costs and Cost Analysis Demographics Developed countries Developing countries Diagnosis related groups DRGs Economic aspects Female Fibrinolytic Agents - administration & dosage Fibrinolytic Agents - economics Hospitals Humans Intravenous administration Ischemia LDCs Male Markov chains Markov processes Medicine and Health Sciences Middle Aged Mortality Neurology Prevention Sensitivity analysis Social Sciences Stroke Stroke - drug therapy Stroke - economics Studies t-Plasminogen activator Thrombolysis Thrombolytic drugs Thrombolytic Therapy - economics Thrombolytic Therapy - methods Time Factors Tissue plasminogen activator Tissue Plasminogen Activator - administration & dosage Tissue Plasminogen Activator - economics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!